|
SHMT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.560300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.875100E-03 |
| Normal-vs-Stage2 |
2.843700E-02 |
| Normal-vs-Stage3 |
3.637700E-03 |
| Normal-vs-Stage4 |
3.66170000000166E-05 |
| Stage1-vs-Stage2 |
5.122800E-01 |
| Stage1-vs-Stage3 |
1.477230E-01 |
| Stage1-vs-Stage4 |
1.298310E-02 |
| Stage2-vs-Stage3 |
6.064000E-01 |
| Stage2-vs-Stage4 |
6.107600E-02 |
| Stage3-vs-Stage4 |
1.280230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.186010E-02 |
| Normal-vs-AfricanAmerican |
1.260900E-03 |
| Normal-vs-Asian |
1.931610E-01 |
| Caucasian-vs-AfricanAmerican |
2.583600E-01 |
| Caucasian-vs-Asian |
7.213800E-01 |
| AfricanAmerican-vs-Asian |
9.749600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.164300E-02 |
| Normal-vs-Female |
3.52190000000308E-05 |
| Male-vs-Female |
1.025750E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.339100E-03 |
| Normal-vs-Extreme_Weight |
1.502110E-02 |
| Normal-vs-Obese |
2.581400E-03 |
| Normal-vs-Extreme_Obese |
5.693000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.864980E-01 |
| Normal_Weight-vs-Obese |
7.448400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.369430E-01 |
| Extreme_Weight-vs-Obese |
2.305400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.315400E-01 |
| Obese-vs-Extreme_Obese |
2.537400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.309700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.590390E-02 |
| Normal-vs-Age(61-80Yrs) |
1.217160E-03 |
| Normal-vs-Age(81-100Yrs) |
1.947430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.678600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.686600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.810400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.903800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.614800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.967400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.954100E-02 |
| Normal-VS-Type2 PRCC |
4.560000E-03 |
| Normal-VS-KIRP CIMP |
3.33330030244383E-10 |
| Normal-VS-Unclassified PRCC |
9.322300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.310300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.62909743659657E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
6.297900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.14980042048774E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
9.726200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.7159000038377E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.213700E-02 |
| Normal-vs-N1 |
2.389900E-04 |
| Normal-vs-N2 |
8.016600E-03 |
| N0-vs-N1 |
5.431500E-02 |
| N0-vs-N2 |
2.964000E-02 |
| N1-vs-N2 |
8.207800E-02 |
|
|
